Profile | GDS4284 / 1555786_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1066.91 | 75 |
GSM687648 | Patient 402 control | 938.289 | 73 |
GSM687653 | Patient 403 control | 786.266 | 71 |
GSM687658 | Patient 404 control | 829.553 | 71 |
GSM687663 | Patient 411 control | 910.994 | 72 |
GSM687668 | Patient 422 control | 1152.85 | 76 |
GSM687673 | Patient 424 control | 1087.17 | 75 |
GSM687678 | Patient 425 control | 1064.72 | 74 |
GSM687683 | Patient 427 control | 1508.74 | 80 |
GSM687688 | Patient 428 control | 1318.5 | 78 |
GSM687695 | Patient 441 control | 1481.32 | 81 |
GSM687699 | Patient 443 control | 1269.2 | 78 |
GSM687704 | Patient 444 control | 717.406 | 69 |
GSM687707 | Patient 448 control | 983.798 | 74 |
GSM687712 | Patient 449 control | 1157.77 | 76 |
GSM687719 | Patient 450 control | 1476.91 | 80 |
GSM687724 | Patient 451 control | 903.07 | 73 |
GSM687728 | Patient 452 control | 865.187 | 72 |
GSM687646 | Patient 401 treated 24h | 1409.8 | 79 |
GSM687649 | Patient 402 treated 24h | 678.585 | 68 |
GSM687665 | Patient 411 treated 24h | 1187.69 | 76 |
GSM687651 | Patient 402 treated 4 weeks | 1027.96 | 74 |
GSM687667 | Patient 411 treated 4 weeks | 994.513 | 73 |
GSM687670 | Patient 422 treated 24h | 979.531 | 73 |
GSM687671 | Patient 422 treated 4 weeks | 960.836 | 73 |
GSM687654 | Patient 403 treated 24h | 1056.36 | 75 |
GSM687675 | Patient 424 treated 24h | 1609.97 | 81 |
GSM687685 | Patient 427 treated 24h | 1032.01 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 764.081 | 70 |
GSM687677 | Patient 424 treated 4 weeks | 1036.34 | 74 |
GSM687687 | Patient 427 treated 4 weeks | 1211.11 | 76 |
GSM687692 | Patient 428 treated 4h | 1363.41 | 78 |
GSM687716 | Patient 449 treated 4h | 906.981 | 73 |
GSM687722 | Patient 450 treated 4h | 1843.06 | 83 |
GSM687680 | Patient 425 treated 24h | 911.767 | 72 |
GSM687690 | Patient 428 treated 24h | 1027.66 | 75 |
GSM687700 | Patient 443 treated 24h | 1791.13 | 83 |
GSM687705 | Patient 444 treated 24h | 1096.07 | 76 |
GSM687714 | Patient 449 treated 24h | 869.786 | 72 |
GSM687721 | Patient 450 treated 24h | 1675.64 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 793.2 | 71 |
GSM687694 | Patient 428 treated 4 weeks | 1352.16 | 78 |
GSM687702 | Patient 443 treated 4 weeks | 1347.16 | 78 |
GSM687718 | Patient 449 treated 4 weeks | 1117.92 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 1089.57 | 75 |
GSM687661 | Patient 404 treated 4h | 839.634 | 71 |
GSM687710 | Patient 448 treated 4h | 1099 | 76 |
GSM687726 | Patient 451 treated 4h | 1237.19 | 77 |
GSM687730 | Patient 452 treated 4h | 2235.34 | 87 |
GSM687660 | Patient 404 treated 24h | 1937.01 | 85 |
GSM687697 | Patient 441 treated 24h | 1904.87 | 84 |
GSM687709 | Patient 448 treated 24h | 1007.96 | 75 |
GSM687725 | Patient 451 treated 24h | 827.829 | 71 |
GSM687729 | Patient 452 treated 24h | 1358.72 | 80 |
GSM687727 | Patient 451 treated 4 weeks | 1127.6 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 1547.52 | 80 |